Brief Report Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/Pharmacol.2.012

Pharmacogenetic Variants in the DPYD and TYMS Genes are Clinically Significant Predictors of Fluoropyrimidine Toxicity: Are We Ready for Use in our Clinical Practice

  • 1Northwell Health Cancer Institute, Lake Success, NY 11042, USA
  • 2Tufts Medical Center, Boston, MA, 02110, USA
  • 3Mayo Clinic, Rochester, MN, Rochester, MN, USA
+ Affiliations - Affiliations

Corresponding Author

Muhammad Wasif Saif,wsaif@northwell.edu

Received Date: June 25, 2020

Accepted Date: August 05, 2020


5-Fluorouracil, Capecitabine, Fluoropyrimidines, DPYD gene

Author Information X